Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

SBHMYSBHMY
10 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in Sino Biopharmaceutical Ltd.

RHUMBLINE ADVISERS previously held 0 shares of SBHMY (Sino Biopharmaceutical Ltd.), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$230,000

Total Shares Change

-6,094

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$9.22
0
2024-Q4
Unchanged
8,855
0.0%
$72,9560.0%$8.19
0
2024-Q3
Unchanged
8,855
0.0%
$85,0430.0%$7.86
0
2024-Q2
Unchanged
8,855
0.0%
$60,5680.0%$6.51
0
2024-Q1
Unchanged
8,855
0.0%
$68,3340.0%$7.90
0
2023-Q4
Unchanged
8,855
0.0%
$78,7030.0%$9.07
0
2023-Q3
Unchanged
8,855
0.0%
$63,9950.0%$6.90
0
2023-Q2
New
8,855
-
$77,0650.0%$9.21
29
2020-Q3
Exited
0
-100.0%
$00.0%$19.09
0
2020-Q2
New
6,094
-
$230,0000.0%$23.11
32

Other major holders of SBHMY: Fisher Asset Management, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used